The use of FEIBA for refractory bleeding in cardiac surgery - a systematic review

References

• Spiess BD, Royston D, Levy JH, et al. Platelet transfusions during CABG are associated with serious adverse outcomes. Transfusion. 2004 Aug;44(8):1143–1148.
   PubMed Web of Science ®Google Scholar
• Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion. 2004 Oct;44(10):1453–1462.
   PubMed Web of Science ®Google Scholar
• Hartmann M, Sucker C, Boehm O, et al. Effects of cardiac surgery on hemostasis. Transfus Med Rev. 2006;20(3):230–241.
   PubMed Web of Science ®Google Scholar
• Balsam LB, Timek TA, Pelletier MP. Factor eight inhibitor bypassing activity (FEIBA) for refractory bleeding in cardiac surgery: review of clinical outcomes. J Card Surg. 2008;23(6):614–621.
   PubMedGoogle Scholar
• Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137(1):209–220.
   PubMed Web of Science ®Google Scholar
• Turecek PL, Varadi K, Gritsch H, et al. FEIBA: mode of action. Haemophilia. 2004;10(Suppl. 2):3–9.
   PubMed Web of Science ®Google Scholar
• Murphy T, Forgie R, MacLeod J, et al. Severe coagulopathy after cardiac surgery: is feiba a viable therapy? Can J Cardiol. 2016;32(10):S113.
   Google Scholar
• Pelletier MP, Rioux M, Hassan A, et al. Factor VIII inhibitor bypassing activity (FEIBA) as an adjunct in post-cardiotomy bleeding. Can J Cardiol. 2011;27(5):S129.
   Google Scholar
• Sera VA, Stevens AE, Song HK, et al. Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial. Pilot Feasibility Stud. 2021;7(1):1–9.
   PubMedGoogle Scholar
• Song HK, Tibayan FA, Kahl EA, et al. Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery. J Thorac Cardiovasc Surg. 2014;147(3):1036–1040.
   PubMedGoogle Scholar
• Rao VK, Lobato RL, Bartlett B, et al. Factor VIII inhibitor bypass activity and recombinant activated factor vii in cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28(5):1221–1226.
   PubMedGoogle Scholar
• Sousa-Uva M, Head SJ, Milojevic M, et al. EACTS guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg. 2017;53(1):5–33. 2018.
   Google Scholar
• Aledort LM. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity - A rebuttal. J Thromb Haemost. 2005;3(4):818–819.
   PubMedGoogle Scholar
• Roman M, Biancari F, Ahmed AB, et al. Prothrombin complex concentrate in cardiac surgery: a systematic review and meta-analysis. Ann Thorac Surg. 2019;107(4):1275–1283.
   PubMedGoogle Scholar
• Warren O, Mandal K, Hadjianastassiou V, et al. Recombinant activated factor vii in cardiac surgery: a systematic review. Ann Thorac Surg. 2007;83(2):707–714.
   PubMed Web of Science ®Google Scholar
• Soran P, Bartlett B, Klanjac M, et al. Comparative study of the effects of recombinant activated factor VII and factor VIII inhibitor bypass activity in profuse bleeding after cardiac surgery. J Cardiothorac Vasc Anesth. 2011;25(3):S17–8.
   Google Scholar
• Rao VK, Bartlett B, Soran D, et al. Comparative study of factor eight inhibitor bypass activity and recombinant activated factor VII in refractory post-cardiopulmonary bypass bleeding. Circulation. 2011;124(21):A17412.
   Google Scholar
• Varadi K, Tangada S, Loeschberger M, et al. Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA® in prophylactic therapy. Haemophilia. 2016;22(4):615–624.
   PubMedGoogle Scholar
• Bolliger D, Lancé MD. Factor concentrate-based approaches to blood conservation in cardiac surgery: european perspectives in 2020. Current Anesthesiology Reports. 2020;10(2):137–146
   Google Scholar
• Warwick R, Mediratta N, Chalmers J, et al. Virchow’s triad and intestinal ischemia post cardiac surgery. Asian Cardiovasc Thorac Ann. 2014;22(8):927–934.
   PubMedGoogle Scholar
• Ehrlich HJ, Henzl MJ, Gomperts ED. Safety of factor VIII inhibitor bypass activity (FEIBA®): 10-year compilation of thrombotic adverse events. Haemophilia. 2002;8(2):83–90.
   PubMed Web of Science ®Google Scholar
• Karkouti K, Bartoszko J, Grewal D, et al. Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: a randomized pilot trial. JAMA Network Open. 2021;4(4):1–15.
   Google Scholar
• Bolliger D, Tanaka KA. Point-of-care coagulation testing in cardiac surgery. Semin Thromb Hemost. 2017;43(4):386–396.
   PubMed Web of Science ®Google Scholar
• Hoffmann T, Assmann A, Dierksen A, et al. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: lessons from an observational study. J Thorac Cardiovasc Surg. 2018;156(4):1564–1573.
   PubMedGoogle Scholar
• Karkouti K, Yau TM, Scott Beattie W, et al. Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth. 2006;53(8):781–794.
   PubMedGoogle Scholar
• Ranucci M, Pavesi M, Mazza E, et al. Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass technique. Perfusion. 1994;9(5):319–326.
   PubMedGoogle Scholar
• Rafiq S, Johansson PI, Kofoed KF, et al. Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial. Platelets. 2017;28(8):786–793.
   PubMed Web of Science ®Google Scholar
• Raphael J, Mazer CD, Subramani S, et al. Society of cardiovascular anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients. J Cardiothorac Vasc Anesth. 2019;33(11):2887–2899.
   PubMed Web of Science ®Google Scholar
• Green L, Roberts N, Cooper J, et al. A pragmatic pilot phase II randomised controlled trial of prothrombin complex concentrates (PCC) versus fresh frozen plasma (FFP) in adult patients who are undergoing heart surgery (PROPHESY). Trials. 2019;20(1):1–8.
   PubMedGoogle Scholar
• Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European society of anaesthesiology. Eur J Anaesthesiol. 2013;30(6):270–382.
   PubMed Web of Science ®Google Scholar